Co-authored publications with mentees

PhD mentee

• Delta-like Ligand 3-Directed ²²⁵Ac Radioimmunotherapy in Neuroendocrine Lung and Prostate Cancer Models.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026

  JSJason S. LewisTTTran T HoangIMIleana MirandaJWJuliana WelkMJMichael J. Morris+1 more →

  PMID: 41887735·PMCID: PMC13224881·DOI·1 citations·Abstract

  With Tran Hoang · Pharmacology (PhD) · Class of 2025

• Delta-like Ligand 3-Directed ²²⁵Ac Radioimmunotherapy in Neuroendocrine Lung and Prostate Cancer Models.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026

  JSJason S. LewisJWJuliana WelkTTTran T HoangIMIleana MirandaMJMichael J. Morris+1 more →

  PMID: 41887735·PMCID: PMC13224881·DOI·1 citations·Abstract

  With Juliana Welk · Pharmacology (PhD)

• Trop-2.2-Directed Radioimmunotherapy with 177Lu, 225Ac, and 212Pb in a Pancreatic Cancer Model.

  Clinical cancer research : an official journal of the American Association for Cancer Research · 2026

  PMID: 41591978·PMCID: PMC13011061·DOI·2 citations·Abstract

  With Olivia Friedl · Pharmacology (PhD)

• IL13Rα2-Targeting Antibodies for Immuno-PET in Solid Malignancies.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025

  JSJason S. LewisJSJustin S HacheyMSMaya S GrahamMAMichael Andrew Postow+2 more →SKSimone Krebs

  PMID: 39978817·PMCID: PMC11960613·DOI·3 citations·Abstract

  With Justin Hachey · Pharmacology (PhD) · Class of 2025

• CEACAM5-Targeted Immuno-PET in Androgen Receptor-Negative Prostate Cancer.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024

  JSJason S. LewisTTTran T Hoang

  PMID: 38782457·PMCID: PMC11218725·DOI·12 citations·Abstract

  With Tran Hoang · Pharmacology (PhD) · Class of 2025

• Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024

  JSJason S. LewisKNKyeara N Mack

  PMID: 38485271·PMCID: PMC10995531·DOI·14 citations·Abstract

  With Kyeara Mack · Pharmacology (PhD) · Class of 2023

• Click Chemistry and Radiochemistry: An Update.

  Bioconjugate chemistry · 2023

  JSJason S. LewisTTTran T HoangBZBrian Zeglis

  PMID: 37737084·PMCID: PMC10655046·DOI·85 citations·Abstract

  With Tran Hoang · Pharmacology (PhD) · Class of 2025

• Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancer.

  Proceedings of the National Academy of Sciences of the United States of America · 2022

  JSJason S. LewisJAJoshua A KorsenCRCharles RudinYCYu Chen

  PMID: 35759660·PMCID: PMC9271187·DOI·49 citations·Abstract

  With Joshua Korsen · Pharmacology (PhD) · Class of 2022

• Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer.

  Nature communications · 2022

  JSJason S. LewisKMKathryn M Tully

  PMID: 35534471·PMCID: PMC9085816·DOI·42 citations·Abstract

  With Kathryn Tully · Pharmacology (PhD) · Class of 2021

• EGFR-Targeted ImmunoPET of UMUC3 Orthotopic Bladder Tumors.

  Molecular imaging and biology · 2022

  JSJason S. LewisTTTran T Hoang

  PMID: 35147837·PMCID: PMC10187976·DOI·9 citations·Abstract

  With Tran Hoang · Pharmacology (PhD) · Class of 2025

• Noninvasive Imaging of CD4+ T Cells in Humanized Mice.

  Molecular cancer therapeutics · 2022

  JSJason S. LewisVLVeronica L NagleMSMaya S GrahamASAndrea SchietingerIKIngo K. Mellinghoff

  PMID: 35131877·PMCID: PMC8983497·DOI·13 citations·Abstract

  With Veronica Nagle · Pharmacology (PhD) · Class of 2021

• Molecular Imaging of Neuroendocrine Prostate Cancer by Targeting Delta-Like Ligand 3.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022

  JSJason S. LewisJAJoshua A KorsenCRCharles RudinYCYu Chen

  PMID: 35058323·PMCID: PMC9454466·DOI·37 citations·Abstract

  With Joshua Korsen · Pharmacology (PhD) · Class of 2022

• Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity.

  Clinical cancer research : an official journal of the American Association for Cancer Research · 2022

  JSJason S. LewisKMKathryn M TullyJAJoshua A KorsenAMAvelyn Mae Delos ReyesCRCharles Rudin

  PMID: 35046060·PMCID: PMC8976830·DOI·67 citations·Abstract

  With Kathryn Tully · Pharmacology (PhD) · Class of 2021

• Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity.

  Clinical cancer research : an official journal of the American Association for Cancer Research · 2022

  JSJason S. LewisJAJoshua A KorsenKMKathryn M TullyAMAvelyn Mae Delos ReyesCRCharles Rudin

  PMID: 35046060·PMCID: PMC8976830·DOI·67 citations·Abstract

  With Joshua Korsen · Pharmacology (PhD) · Class of 2022

• ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody.

  Clinical cancer research : an official journal of the American Association for Cancer Research · 2022

  JSJason S. LewisKNKyeara N MackBZBrian Zeglis

  PMID: 34907079·PMCID: PMC8898287·DOI·33 citations·Abstract

  With Kyeara Mack · Pharmacology (PhD) · Class of 2023

• Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET Probe.

  Clinical cancer research : an official journal of the American Association for Cancer Research · 2021

  JSJason S. LewisVLVeronica L NaglePNPengju NieGPGeorge P LiaoYLYue-Ming Li

  PMID: 34475100·PMCID: PMC8610083·DOI·7 citations·Abstract

  With Veronica Nagle · Pharmacology (PhD) · Class of 2021

• Influence of Fc Modifications and IgG Subclass on Biodistribution of Humanized Antibodies Targeting L1CAM.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021

  JSJason S. LewisJAJoshua A KorsenBNBrandon NemiebokaNCNai-Kong Cheung

  PMID: 34353869·PMCID: PMC8973293·DOI·11 citations·Abstract

  With Joshua Korsen · Pharmacology (PhD) · Class of 2022

• ERK Inhibition Improves Anti-PD-L1 Immune Checkpoint Blockade in Preclinical Pancreatic Ductal Adenocarcinoma.

  Molecular cancer therapeutics · 2021

  JSJason S. LewisVLVeronica L NagleKNKyeara N Mack

  PMID: 34349003·PMCID: PMC8492510·DOI·16 citations·Abstract

  With Veronica Nagle · Pharmacology (PhD) · Class of 2021

• ERK Inhibition Improves Anti-PD-L1 Immune Checkpoint Blockade in Preclinical Pancreatic Ductal Adenocarcinoma.

  Molecular cancer therapeutics · 2021

  JSJason S. LewisKNKyeara N MackVLVeronica L Nagle

  PMID: 34349003·PMCID: PMC8492510·DOI·16 citations·Abstract

  With Kyeara Mack · Pharmacology (PhD) · Class of 2023

• Synthesis and Comparative In Vivo Evaluation of Site-Specifically Labeled Radioimmunoconjugates for DLL3-Targeted ImmunoPET.

  Bioconjugate chemistry · 2021

  JSJason S. LewisJAJoshua A KorsenCRCharles RudinBZBrian Zeglis

  PMID: 33835770·PMCID: PMC8295218·DOI·19 citations·Abstract

  With Joshua Korsen · Pharmacology (PhD) · Class of 2022

• Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021

  JSJason S. LewisKNKyeara N MackJGJan Grimm

  PMID: 33712530·PMCID: PMC8724889·DOI·12 citations·Abstract

  With Kyeara Mack · Pharmacology (PhD) · Class of 2023

• Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [⁶⁴Cu]Cu-NOTA-anti-CD8 PET.

  Clinical cancer research : an official journal of the American Association for Cancer Research · 2021

  JSJason S. LewisVLVeronica L NagleMSMaya S GrahamLFLuis F ParadaASAndrea Schietinger+1 more →

  PMID: 33495310·PMCID: PMC8026513·DOI·45 citations·Abstract

  With Veronica Nagle · Pharmacology (PhD) · Class of 2021

• Antibody-Based Molecular Imaging

  Molecular Imaging Principles and Practice · 2021

  Source: Scopus·DOI

  With Kathryn Tully · Pharmacology (PhD) · Class of 2021

• Antibody-Based Molecular Imaging

  Molecular Imaging Principles and Practice · 2021

  Source: Scopus·DOI

  With Veronica Nagle · Pharmacology (PhD) · Class of 2021

• Antibody-Based Molecular Imaging

  Molecular Imaging Principles and Practice · 2021

  Source: Scopus·DOI

  With Joshua Korsen · Pharmacology (PhD) · Class of 2022

• Predicting CAR-T cell Immunotherapy Success through ImmunoPET.

  Clinical cancer research : an official journal of the American Association for Cancer Research · 2020

  JSJason S. LewisVLVeronica L Nagle

  PMID: 33328345·PMCID: PMC7887102·DOI·6 citations·Abstract

  With Veronica Nagle · Pharmacology (PhD) · Class of 2021

• Polyazamacrocycle Ligands Facilitate ⁸⁹Zr Radiochemistry and Yield ⁸⁹Zr Complexes with Remarkable Stability.

  Inorganic chemistry · 2020

  JSJason S. LewisVLVeronica L Nagle

  PMID: 33169605·PMCID: PMC8300002·DOI·27 citations·Abstract

  With Veronica Nagle · Pharmacology (PhD) · Class of 2021

• ImmunoPET Imaging of Pancreatic Tumors with ⁸⁹Zr-Labeled Gold Nanoparticle-Antibody Conjugates.

  Molecular imaging and biology · 2020

  JSJason S. LewisJAJoshua A Korsen

  PMID: 32909244·PMCID: PMC7785666·DOI·30 citations·Abstract

  With Joshua Korsen · Pharmacology (PhD) · Class of 2022

• Demarcation of Sepsis-Induced Peripheral and Central Acidosis with pH (Low) Insertion Cycle Peptide.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020

  JSJason S. LewisVLVeronica L Nagle

  PMID: 32005774·PMCID: PMC7456172·DOI·14 citations·Abstract

  With Veronica Nagle · Pharmacology (PhD) · Class of 2021

• Improved synthesis of the bifunctional chelator p-SCN-Bn-HOPO.

  Organic & biomolecular chemistry · 2019

  JSJason S. LewisKMKathryn M TullySPShashikanth PonnalaJWJohn W Babich

  PMID: 31268109·PMCID: PMC6640124·DOI·14 citations·Abstract

  With Kathryn Tully · Pharmacology (PhD) · Class of 2021

• A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals.

  Nuclear medicine and biology · 2019

  JSJason S. LewisKMKathryn M Tully

  PMID: 31128476·PMCID: PMC6599726·DOI·54 citations·Abstract

  With Kathryn Tully · Pharmacology (PhD) · Class of 2021

• Toward the Optimization of Click-Mediated Pretargeted Radioimmunotherapy.

  Molecular pharmaceutics · 2019

  JSJason S. LewisKMKathryn M TullyBZBrian Zeglis

  PMID: 30912951·PMCID: PMC7047588·DOI·25 citations·Abstract

  With Kathryn Tully · Pharmacology (PhD) · Class of 2021

• Molecular imaging companion diagnostics

  Companion and Complementary Diagnostics from Biomarker Discovery to Clinical Implementation · 2019

  Source: Scopus·DOI

  With Kathryn Tully · Pharmacology (PhD) · Class of 2021

• Bioorthogonal Masking of Circulating Antibody-TCO Groups Using Tetrazine-Functionalized Dextran Polymers.

  Bioconjugate chemistry · 2018

  JSJason S. LewisKMKathryn M TullyTRThomas Reiner

  PMID: 29378403·PMCID: PMC6004324·DOI·43 citations·Abstract

  With Kathryn Tully · Pharmacology (PhD) · Class of 2021